Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Report of ThromboSol efficacy presented at hematology congress

Jan. 9, 1998

BioChem Pharma/Scriptgen conclude licensing and equity agreements

Jan. 8, 1998

Drug discovery collaboration established by Aurora and Merck

Jan. 7, 1998

CIMA terminates one and initiates another OraSolv agreement

Jan. 2, 1998

Genetronics develops new transdermal delivery method suitable for large molecules and genes

Dec. 30, 1997

Bayer/Genzyme drug discovery collaboration

Dec. 24, 1997

Therapeutics discovery collaboration formed by Ontogeny and ArQule

Dec. 23, 1997

New prodrug approach claimed by Merck & Co.

Dec. 23, 1997

Cel-Sci and NCI to test L.E.A.P.S. in NCI animal models of cancer

Dec. 22, 1997

Antibody-based therapeutics alliance formed by CAT and Icos

Dec. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...